Page last updated: 2024-11-06

prednisolone and Muscle Tissue Neoplasms

prednisolone has been researched along with Muscle Tissue Neoplasms in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navinan, MR1
Liyanage, I1
Herath, S1
Yudhishdran, J1
Shivanthan, C1
Beneragama, D1
Kulatunga, A1
Tsuma, Y1
Miyachi, M1
Ouchi, K1
Tsuchiya, K1
Iehara, T1
Naitoh, Y1
Konishi, E1
Yanagisawa, A1
Hosoi, H1

Other Studies

2 other studies available for prednisolone and Muscle Tissue Neoplasms

ArticleYear
Inoperable inflammatory myofibroblastic tumour of the para-nasal sinuses and orbit with recurrence responding to methotrexate and prednisolone: a case report.
    BMC research notes, 2015, Feb-04, Volume: 8

    Topics: Adult; Antimetabolites, Antineoplastic; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Me

2015
Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:8

    Topics: Adolescent; Conservative Treatment; Cyclooxygenase 2 Inhibitors; Cystectomy; Humans; Inflammation; M

2016